Retrospective analysis of interventional treatment of hepatic metastasis from gastroenteropancreatic neuroendocrine tumors

被引:0
|
作者
Peng Liu [1 ]
Xu Zhu [1 ]
Jie Li [2 ]
Ming Lu [2 ]
Jiahua Leng [3 ]
Ying Li [4 ]
Jiangyuan Yu [5 ]
机构
[1] Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Interventional Therapy,Peking University Cancer Hospital & Institute
[2] Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Gastroenterological Oncology,Peking University Cancer Hospital & Institute
[3] Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Center of Gastrointestinal Surgery Unit Ⅲ,Peking University Cancer Hospital & Institute
[4] Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Radiology,Peking University Cancer Hospital & Institute
[5] Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Nuclear Medicine,Peking University Cancer Hospital & Institute
基金
中国国家自然科学基金;
关键词
Gastroenteropancreatic neuroendocrine tumors; hepatic metastasis; angiography; interventional treatment; retrospective analysis;
D O I
暂无
中图分类号
R735 [消化系肿瘤];
学科分类号
100214 ;
摘要
Objective: To analyze the angiography appearance of liver metastases from gastroenteropancreatic neuroendocrine tumors(GEP-NETs),and evaluate the clinical efficacy and prognostic factors of interventional treatment for hepatic metastases.Methods: Fifty GEP-NETs patients with hepatic metastases were treated from January 2012 to December 2016,and received transarterial embolization(TAE) in the hepatic tumor or hepatic arterial infusion chemotherapy(HAIC).All patients received 179 times of the intervention therapy in total.Results: Blood supplies were identified in the 50 cases with angiography,which showed that 35 cases had abundant vessels,while 15 cases had poor blood supply.Twenty-two cases were found either collateral blood supply,or portal vein invasion or arterial-portal vein fistula.The best curative efficacy was complete remission(CR)in 4 cases,partial remission(PR) in 28 cases and stable disease(SD) in 18 cases during the process of treatment.The angiography(P=0.047) and the frequency of intervention(P=0.037) showed significantly statistical difference with Kaplan-Meier analysis.The Cox analysis showed that more than 3 times of interventional therapy was an independent prognostic factor.Conclusions: Interventional treatment is safe and effective for GEP-NETs,and is beneficial to patients with main hepatic metastases after endocrine therapy.
引用
收藏
页码:581 / 586
页数:6
相关论文
共 50 条
  • [31] Quality of Life in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors Receiving Peptide Receptor Radionuclide Therapy: Information from a Monitoring Program in Clinical Routine
    Martini, Caroline
    Buxbaum, Sabine
    Rodrigues, Margarida
    Nilica, Bernhard
    Scarpa, Lorenza
    Holzner, Bernhard
    Virgolini, Irene
    Gamper, Eva-Maria
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (10) : 1566 - 1573
  • [32] Interim Analyses LANREL07484: Response to Treatment and Self-Reported Satisfaction in Symptoms in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with Lanreotide Autogel in South Africa
    Geldenhuys, D.
    Jacobs, C.
    Rapoport, B.
    Fourie, S.
    Szpak, W.
    Rodrigues, S.
    Pirjol, A.
    Narsai, N.
    Harris, J.
    Botha, M.
    Jonas, N.
    McMaster, A.
    NEUROENDOCRINOLOGY, 2018, 106 : 194 - 194
  • [33] The role of radiofrequency ablation for treatment of metachronous isolated hepatic metastasis from colorectal cancer
    Lee, Byoung Chul
    Lee, Hyun Gu
    Park, In Ja
    Kim, So Yeon
    Kim, Ki-Hun
    Lee, Jae Hoon
    Kim, Chan Wook
    Lee, Jong Lyul
    Yoon, Yong Sik
    Lim, Seok-Byung
    Yu, Chang Sik
    Kim, Jin Cheon
    MEDICINE, 2016, 95 (39)
  • [34] Long term results of hepatic resection or orthotopic liver transplantation in patients with liver metastases from gastrointestinal neuroendocrine tumors
    Pasqual, Enrico Maria
    Bertozzi, Serena
    Londero, Ambrogio P.
    Bacchetti, Stefano
    Lorenzin, Dario
    Pasqualucci, Alberto
    Moccheggiani, Federico
    Federici, Alen
    Vivaverlli, Marco
    Risaliti, Andrea
    ONCOLOGY LETTERS, 2016, 12 (05) : 3563 - 3570
  • [35] Applying Reflective Multicriteria Decision Analysis (MCDA) to Patient–Clinician Shared Decision-Making on the Management of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) in the Spanish Context
    Monika Wagner
    Dima Samaha
    Jesus Cuervo
    Harshila Patel
    Marta Martinez
    William M. O’Neil
    Paula Jimenez-Fonseca
    Advances in Therapy, 2018, 35 : 1215 - 1231
  • [36] Applying Reflective Multicriteria Decision Analysis (MCDA) to Patient-Clinician Shared Decision-Making on the Management of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) in the Spanish Context
    Wagner, Monika
    Samaha, Dima
    Cuervo, Jesus
    Patel, Harshila
    Martinez, Marta
    O'Neil, William M.
    Jimenez-Fonseca, Paula
    ADVANCES IN THERAPY, 2018, 35 (08) : 1215 - 1231
  • [37] Routine Use of Pamidronate in NSCLC Patients with Bone Metastasis: Results from a Retrospective Analysis
    Spizzo, Gilbert
    Seeber, Andreas
    Mitterer, Manfred
    ANTICANCER RESEARCH, 2009, 29 (12) : 5245 - 5249
  • [38] A bibliometric and visualized analysis of interventional treatment for intracranial atherosclerotic stenosis (from 2004 to 2023)
    Du, Kai
    Gong, Jieqin
    Li, Jizhen
    Chen, Hanchun
    Fang, Qi
    NEUROSURGICAL REVIEW, 2025, 48 (01)
  • [39] Four resections for hepatic metastasis from gastric cancer: histochemical analysis of cell proliferation, apoptosis, and angiogenesis
    Koide, N
    Watanabe, H
    Shimozawa, N
    Hanazaki, K
    Kajikawa, S
    Adachi, W
    Amano, J
    JOURNAL OF GASTROENTEROLOGY, 2000, 35 (02) : 150 - 154
  • [40] Clinicopathological and survival features of neuroendocrine tumors: A retrospective analysis of 153 cases, our current remarks on a heterogeneous tumor group, and still unmet future expectations
    Kahraman, Seda
    Bardakci, Murat
    Aykan, Musa B.
    Yasar, Serkan
    Erol, Cihan
    Hizal, Mutlu
    Akinci, M. Bulent
    Kos, Fahriye Tugba
    Dede, Didem S.
    Karadurmus, Nuri
    Yalcin, Suayib
    Sendur, Mehmet Ali N.
    Yalcin, Bulent
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (02) : 347 - 354